OPA Asks 340B Hospitals About Botox Use

by Admin | February 7, 2013 8:55 am

February 7, 2013—The Office of Pharmacy Affairs (OPA) sent letters to 340B hospitals in late January requesting details about their use of the Allergan drugs Botox and Botox Cosmetic. Although Botox is perhaps best known for its cosmetic use, it is widely used medically to treat specific neuromuscular conditions affecting the upper limbs, eyes, and neck. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2013/02/opa-asks-340b-hospitals-about-botox-use/

Copyright ©2026 340binformed.org unless otherwise noted.